JP2025512877A5 - - Google Patents
Info
- Publication number
- JP2025512877A5 JP2025512877A5 JP2024557886A JP2024557886A JP2025512877A5 JP 2025512877 A5 JP2025512877 A5 JP 2025512877A5 JP 2024557886 A JP2024557886 A JP 2024557886A JP 2024557886 A JP2024557886 A JP 2024557886A JP 2025512877 A5 JP2025512877 A5 JP 2025512877A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- formula
- hydrogen
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263326625P | 2022-04-01 | 2022-04-01 | |
| US63/326,625 | 2022-04-01 | ||
| US202363482670P | 2023-02-01 | 2023-02-01 | |
| US63/482,670 | 2023-02-01 | ||
| PCT/US2023/017201 WO2023192642A2 (en) | 2022-04-01 | 2023-03-31 | Methods and compounds for modulating huntington's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512877A JP2025512877A (ja) | 2025-04-22 |
| JP2025512877A5 true JP2025512877A5 (https=) | 2026-04-08 |
Family
ID=88203356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557886A Pending JP2025512877A (ja) | 2022-04-01 | 2023-03-31 | ハンチントン病を調節するための方法及び化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20240058460A1 (https=) |
| EP (1) | EP4504339A2 (https=) |
| JP (1) | JP2025512877A (https=) |
| KR (1) | KR20250016096A (https=) |
| CN (1) | CN119584961A (https=) |
| AU (1) | AU2023241739A1 (https=) |
| CA (1) | CA3247116A1 (https=) |
| IL (1) | IL315965A (https=) |
| MX (1) | MX2024012094A (https=) |
| TW (1) | TW202404642A (https=) |
| WO (1) | WO2023192642A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025122764A1 (en) * | 2023-12-08 | 2025-06-12 | Design Therapeutics, Inc. | Methods and compounds for modulating inherited genetic diseases |
| WO2026015815A1 (en) * | 2024-07-12 | 2026-01-15 | Design Therapeutics, Inc. | Methods of treating haploinsufficiency disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10517877B2 (en) * | 2016-03-30 | 2019-12-31 | Wisconsin Alumni Research Foundation | Compounds and methods for modulating frataxin expression |
| EP4234549A1 (en) * | 2018-05-22 | 2023-08-30 | Design Therapeutics, Inc. | Methods and compounds for the treatment of genetic disease |
| CN121045206A (zh) * | 2020-02-03 | 2025-12-02 | 设计治疗公司 | 用于治疗遗传疾病的方法和化合物 |
| WO2022126000A1 (en) * | 2020-12-11 | 2022-06-16 | Design Therapeutics, Inc. | Methods and compounds for modulating myotonic dystrophy 1 |
-
2023
- 2023-03-31 KR KR1020247036140A patent/KR20250016096A/ko active Pending
- 2023-03-31 JP JP2024557886A patent/JP2025512877A/ja active Pending
- 2023-03-31 IL IL315965A patent/IL315965A/en unknown
- 2023-03-31 CA CA3247116A patent/CA3247116A1/en active Pending
- 2023-03-31 TW TW112112601A patent/TW202404642A/zh unknown
- 2023-03-31 CN CN202380037169.1A patent/CN119584961A/zh active Pending
- 2023-03-31 WO PCT/US2023/017201 patent/WO2023192642A2/en not_active Ceased
- 2023-03-31 EP EP23781908.1A patent/EP4504339A2/en active Pending
- 2023-03-31 AU AU2023241739A patent/AU2023241739A1/en active Pending
- 2023-10-03 US US18/480,353 patent/US20240058460A1/en active Pending
- 2023-10-03 US US18/480,117 patent/US20240042046A1/en active Pending
-
2024
- 2024-09-30 MX MX2024012094A patent/MX2024012094A/es unknown